Roy MA - Search Results

1

Treatment with psychostimulants and atomoxetine in people with psychotic disorders: reassessing the risk of clinical deterioration in a real-world setting.

Corbeil O, Brodeur S, Courteau J, Béchard L, Huot-Lavoie M, Angelopoulos E, Di Stefano S, Marrone E, Vanasse A, Fleury MJ, Stip E, Lesage A, Joober R, Demers MF, Roy MA. Corbeil O, et al. Among authors: roy ma. Br J Psychiatry. 2024 Mar;224(3):98-105. doi: 10.1192/bjp.2023.149. Br J Psychiatry. 2024. PMID: 38044665 Free PMC article.

2

Psychiatric disorders in multiple sclerosis.

Stip E, Roy M. Stip E, et al. Can J Psychiatry. 1997 Apr;42(3):324-5. doi: 10.1177/070674379704200324. Can J Psychiatry. 1997. PMID: 9114953 No abstract available.

3

Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics.

Alméras N, Després JP, Villeneuve J, Demers MF, Roy MA, Cadrin C, Mottard JP, Bouchard RH. Alméras N, et al. Among authors: roy ma. J Clin Psychiatry. 2004 Apr;65(4):557-64. doi: 10.4088/jcp.v65n0417. J Clin Psychiatry. 2004. PMID: 15119921

4

Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial.

Potvin S, Stip E, Lipp O, Elie R, Mancini-Marië A, Demers MF, Roy MA, Bouchard RH, Gendron A. Potvin S, et al. Among authors: roy ma. Curr Med Res Opin. 2006 Jul;22(7):1277-85. doi: 10.1185/030079906X112561. Curr Med Res Opin. 2006. PMID: 16834826

5

Informative phenotypes for genetic studies of psychiatric disorders.

Szatmari P, Maziade M, Zwaigenbaum L, Mérette C, Roy MA, Joober R, Palmour R. Szatmari P, et al. Among authors: roy ma. Am J Med Genet B Neuropsychiatr Genet. 2007 Jul 5;144B(5):581-8. doi: 10.1002/ajmg.b.30426. Am J Med Genet B Neuropsychiatr Genet. 2007. PMID: 17219386 Review.

6

Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.

Potvin S, Stip E, Lipp O, Roy MA, Demers MF, Bouchard RH, Gendron A. Potvin S, et al. Among authors: roy ma. Am J Drug Alcohol Abuse. 2008;34(1):75-82. doi: 10.1080/00952990701764631. Am J Drug Alcohol Abuse. 2008. PMID: 18161645

7

Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy.

Potvin S, Kouassi E, Lipp O, Bouchard RH, Roy MA, Demers MF, Gendron A, Astarita G, Piomelli D, Stip E. Potvin S, et al. Among authors: roy ma. J Psychopharmacol. 2008 May;22(3):262-9. doi: 10.1177/0269881107083816. J Psychopharmacol. 2008. PMID: 18308802 Free article.

8

Comorbidity between anxiety disorders and recent-onset psychotic disorders.

Roy MA, Achim AM, Vallières C, Labbé A, Mérette C, Maziade M, Demers MF, Bouchard RH. Roy MA, et al. Schizophr Res. 2015 Aug;166(1-3):353-4. doi: 10.1016/j.schres.2015.04.041. Epub 2015 May 23. Schizophr Res. 2015. PMID: 26004685 No abstract available.

9

What Is the Place of Clozapine in the Treatment of Early Psychosis in Canada?

Williams R, Malla A, Roy MA, Joober R, Manchanda R, Tibbo P, Banks N, Agid O. Williams R, et al. Among authors: roy ma. Can J Psychiatry. 2017 Feb;62(2):109-114. doi: 10.1177/0706743716651049. Epub 2016 Jul 9. Can J Psychiatry. 2017. PMID: 27310245 Free PMC article. Review.

10

[Initiating an antipsychotic drug treatment for schizophrenia: the situation in Quebec, Canada, from 1998 to 2006].

Carrier JD, Blais L, Cohen A, Courteau J, Roberge P, Larouche A, Grignon S, Fleury MJ, Lesage A, Demers MF, Roy MA, Delorme A, Vanasse A. Carrier JD, et al. Among authors: roy ma. Sante Ment Que. 2017 Spring;42(1):85-103. Sante Ment Que. 2017. PMID: 28792563 Free article. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

274 results

Search Page